132 related articles for article (PubMed ID: 1100959)
1. Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
Hamzah M; Kosasih A
Lepr Rev; 1975 Jun; 46(2 Suppl):181-7. PubMed ID: 1100959
[No Abstract] [Full Text] [Related]
2. Treatment of leprosy with rifampicin and isoprodian (L73A).
Terencio de las Aguas J
Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
[No Abstract] [Full Text] [Related]
3. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
Freerksen E
Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
[No Abstract] [Full Text] [Related]
4. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Krenzien HN
Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
[No Abstract] [Full Text] [Related]
5. Rifampicin and isoprodian in combination in the treatment of leprosy.
Depasquale G
Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
[No Abstract] [Full Text] [Related]
6. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Innami S; Leguizamón OR; Alvarenga AE
Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
[No Abstract] [Full Text] [Related]
7. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
Rohde R
Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
[No Abstract] [Full Text] [Related]
8. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
Aschhoff M
Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
[No Abstract] [Full Text] [Related]
9. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
10. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Depasquale G
Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
[No Abstract] [Full Text] [Related]
11. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
Sighart H; Opl G; Weirich H
Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180
[No Abstract] [Full Text] [Related]
13. [New drugs in the treatment of leprosy].
De Las Aguas JT
Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
[TBL] [Abstract][Full Text] [Related]
14. [A preliminary report on the clinical efficacy of isoprodian (author's transl)].
Opl G; Benkö M
Prax Pneumol; 1976 Mar; 30(3):154-7. PubMed ID: 785433
[No Abstract] [Full Text] [Related]
15. Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
Sighart H
Scand J Respir Dis Suppl; 1978; 102():60-1. PubMed ID: 356259
[No Abstract] [Full Text] [Related]
16. [Isoniazio, prothionamide and diafenylsulphone (isoprodian) in the therapy of previously untreated pulmonary (author's transl)].
Müller W
Prax Pneumol; 1976 Mar; 30(3):157-64. PubMed ID: 785434
[No Abstract] [Full Text] [Related]
17. Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
Kleeberg HH
S Afr Med J; 1986 Feb; 69(3):161. PubMed ID: 3511545
[No Abstract] [Full Text] [Related]
18. First assessment of the Malta Leprosy Eradication Project.
Leiker DL
Lepr Rev; 1986; 57 Suppl 3():42-6. PubMed ID: 3573959
[No Abstract] [Full Text] [Related]
19. [Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Pereira V
Prax Pneumol; 1976 Sep; 30(9):584-7. PubMed ID: 967829
[No Abstract] [Full Text] [Related]
20. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
Pattyn SR; Portaels F; Van Loo G; Van den Breen L
Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]